The group’s principal activity is to develop bronchoscopic catheter based method of delivering vapor to emphysematous lung regions. The group applies energy expand and offering the patient improved overall breathing mechanics. The group’s Bronchoscopic Thermal Vapor Ablation (BTVA) technology is a potentially safe and effective therapy for patients diagnosed with emphysema. The group operates from the United States.
